Table 2.
Correlationship between the clinicopathological features of COAD patients and the level of KRT17 (*P < 0.05). – – Affiliated Hospital of Nantong University
| KRT 17 level |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Clinicalpathological fetures | Low(n = 39) | High(n = 39) | Total | X2 | P value | |||||
| Gender | 2.731 | 0.098 | ||||||||
| Male | 24 | 27 | 51 | |||||||
| Female | 18 | 9 | 27 | |||||||
| Age(years) | 0.542 | 0.462 | ||||||||
| ≤60 | 21 | 15 | 36 | |||||||
| >60 | 21 | 21 | 42 | |||||||
| Tumor diameter(cm) | 6.798 | 0.009 | ||||||||
| ≤4 | 18 | 26 | 44 | |||||||
| >4 | 24 | 10 | 34 | |||||||
| Tumor location | 0.125 | 0.724 | ||||||||
| Up/ Middle | 17 | 16 | 33 | |||||||
| Down | 25 | 20 | 45 | |||||||
| Tumor differentiation | 0.489 | 0.484 | ||||||||
| High | 20 | 20 | ||||||||
| Low | 22 | 16 | ||||||||
| CEA level(ng/ml) | 1.697 | 0.193 | ||||||||
| ≤5 | 27 | 28 | 55 | |||||||
| >5 | 15 | 8 | 23 | |||||||
| TNM stage | 19.192 | 0.000 | ||||||||
| I/II | 13 | 29 | 42 | |||||||
| III | 29 | 7 | 36 | |||||||
| T stage | 8.254 | 0.004 | ||||||||
| 1/2 | 10 | 20 | 30 | |||||||
| 3/4 | 32 | 16 | 48 | |||||||
| Survival state | 14.480 | 0.000 | ||||||||
| Death | 10 | 24 | 34 | |||||||
| Alive | 32 | 12 | 44 | |||||||
| N stage | 31.536 | 0.000 | ||||||||
| 0/1 | 17 | 36 | 53 | |||||||
| 2/3 | 25 | 0 | 25 | |||||||
| MVD | 29.534 | 0.000 | ||||||||
| High | 29 | 3 | 32 | |||||||
| Low | 13 | 33 | 46 | |||||||